Short interfering RNA therapeutics: Nanocarriers, prospects and limitations

IET Nanobiotechnology

Volumn 9, Issue 6, 2015, Pages 386-395

  Mehrotra, Neha ^a   Tripathi, Ravi Mani ^a  

^a AMITY UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES; NANOPARTICLES; NANOSTRUCTURES; NUCLEIC ACIDS;

CLINICAL TESTING; DELIVERY SYSTEMS; ENDOSOMAL ESCAPES; NANOPARTICLE FORMULATION; NANOPARTICLE SYSTEMS; SHORT INTERFERING RNA; TARGETED DELIVERY; TARGETED DELIVERY SYSTEMS;

RNA;

NANOCAPSULE; SMALL INTERFERING RNA;

ANIMAL; CHEMISTRY; EVIDENCE BASED MEDICINE; GENE SILENCING; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; PROCEDURES; TRENDS; ULTRASTRUCTURE;

ANIMALS; EVIDENCE-BASED MEDICINE; GENE SILENCING; GENETIC THERAPY; HUMANS; NANOCAPSULES; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84949570497     PISSN: 17518741     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-nbt.2015.0018     Document Type: Review

References (100)

1. Stephenson, M.L., Zamecnik, P.C.: 'Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide', Proc. Natl. Acad. Sci. US A, 1978, 75, (1), pp. 285-288
2. Zamecnik, P.C., Stephenson, M.L.: 'Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide', Proc. Natl. Acad. Sci. USA, 1978, 75, (1), pp. 280-284
3. Fire, A., Xu, S., Montgomery, M.K, Kostas, S.A., Driver, S.E., Mello, C.C.: 'Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans', Nature, 1998, 391, (6669), pp. 806-811
4. McCaffrey, A.P., Meuse, L., Pham, T.T., Conklin, D.S., Hannon, G.J., Kay, M.A.: 'RNA interference in adult mice', Nature, 2002, 418, (6893), pp. 38-39
5. Ketting, R.F., Fischer, S.E., Bernstein, E., Sijen, T., Hannon, G.J., Plasterk, R.H.: 'Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. Elegans', Genes Dev., 2001, 15, (20), pp. 2654-2659
6. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T.: 'Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells', Nature, 2001, 411, (6836), pp. 494-498
7. John, M., Constien, R., Akinc, A., et al.: 'Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway', Nature, 2007, 449, (7163), pp. 745-747
8. Zhou, J., Shum, K.T., Burnett, J.C., Rossi, J.J.: 'Nanop article-based delivery of RNAi therapeutics: progress and challenges', Pharmaceuticals (Basel), 2013, 6, (1), pp. 85-107
9. Tang, G.: 'siRNA and miRNA: an insight into RISCs', Trends Biochem. Sci., 2005, 30, (2), pp. 106-114
10. Doi, N., Zenno, S., Ueda, R., Ohki-Hamazaki, H., Ui-Tei, K., Saigo, K.: ' Short-interfering-RNA-mediated gene silencing in mammalian cells requires dicer and Eif2c translation initiation factors', Curr. Biol., 2003, 13, (1), pp. 41-46
11. Rand, T.A, Ginalski, K., Grishin, N.V., Wang, X.: 'Biochemical identification of argonaute 2 as the sole protein required for RNA-induced silencing complex activity', Proc. Natl. Acad. Sci. USA, 2004, 101, (40), pp. 14385-14389
12. Tabara, H., Sarkissian, M., Kelly, W.G., etal.: 'TheRde-1 gene, RNA interference, and transposon silencing in C. Elegans', Cell, 1999, 99, (2), pp. 123-132
13. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G, Tuschl, T.: 'Human argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs', Mol. Cell, 2004, 15, (2), pp. 185-197
14. Parker, J.S., Roe, S.M., Barford, D.: 'Crystal structure of a PIWI protein suggests mechanisms for siRNA recognition and slicer activity', EMBO J., 2004, 23, (24), pp. 4727-4737
15. Paddison, P.J., Caudy, A.A., Bernstein, E., Hannon, G.J., Conklin, D.S.: 'Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells', Genes Dev., 2002, 16, (8), pp. 948-958
16. Grimm, D.: 'Small silencing RNAs: state-of-the-art', Adv. DrugDeliv. Rev., 2009, 61, (9), pp. 672-703
17. Esau, C.C., Monia, B.P.: 'Therapeutic potential for microRNAs', Adv. Drug Deliv. Rev., 2007, 59, (2-3), pp. 101-114
18. Takahashi, Y., Yamaoka, K., Nishikawa, M., Takakura, Y.: 'Quantitative and temporal analysis of gene silencing in tumor cells induced by small interfering RNA or short hairpin RNA expressed from plasmid vectors', J. Pharm. Sci., 2009, 98, (1), pp. 74-80
19. Reischl, D., Zimmer, A.: 'Drug delivery of siRNA therapeutics: potentials and limits of nanosystems', Nanomedicine, 2009, 5, (1), pp. 8-20
20. Tomar, R.S., Matta, H., Chaudhary, P.M.: 'Use of adeno-associated viral vector for delivery of small interfering RNA', Oncogene, 2003, 22, (36), pp. 5712-5715
21. Castanotto, D., Rossi, J.J.: 'The promises and pitfalls of RNA-interference-based therapeutics', Nature, 2009, 457, (7228), pp. 426-433
22. Hobel, S., Koburger, I., John, M., et al.: 'Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with bevacizumab', J. Gene Med., 2010, 12, (3), pp. 287-300
23. Shukla, S., Sumaria, C.S., Pradeepkumar, P.I.: 'Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook', ChemMedChem, 2010, 5, (3), pp. 328-349
24. Petros, R.A., DeSimone, J.M.: 'Strategies in the design of nanoparticles for therapeutic applications', Nat. Rev. DrugDiscov., 2010, 9, (8), pp. 615-627
25. Li, W., Szoka, F.C. Jr.: 'Lipid-based nanoparticles for nucleic acid delivery', Pharm. Res., 2007, 24, (3), pp. 438-449
26. Gomes-da-Silva, L.C., Fonseca, N.A., Moura, V., Pedroso de Lima, M.C., Simoes, S., Moreira, J.N.: 'Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges', Acc. Chem. Res., 2012, 45, (7), pp.1163-1171
27. Templeton, N.S., Lasic, D.D., Frederik, P.M., Strey, H.H., Roberts, D.D., Pavlakis, G.N.: 'Improved DNA: liposome complexes for increased systemic delivery and gene expression', Nat. Biotechnol, 1997, 15, (7), pp. 647-652
28. Landen, C.N. Jr., Chavez-Reyes, A., Bucana, C, et al.: 'Therapeutic Epha2 gene targeting in vivo using neutral liposomal small interfering RNA delivery', Cancer Res., 2005, 65, (15), pp. 6910-6918
29. Santel, A., Aleku, M., Keil, O., et al: 'RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy', Gene Ther., 2006, 13, (18), pp. 1360-1370
30. Muller, R.H., Mader, K., Gohla, S.: 'Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art', Eur. J. Pharm. Biopharm., 2000, 50, (1), pp. 161-177
31. Lobovkina, T., Jacobson, G.B., Gonzalez-Gonzalez, E., et al: 'In vivo sustained release of siRNA from solid lipid nanoparticles', ACS Nano, 2011, 5, (12), pp. 9977-9983
32. Mukherjee, S., Ray, S., Thakur, R.S.: 'Solid lipid nanoparticles: a modern formulation approach in drug delivery system', Indian J. Pharm. Sci., 2009, 71, (4), pp. 349-358
33. Morrissey, D.V., Lockridge, J.A., Shaw, L., et al.: 'Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs', Nat. Biotechnol, 2005, 23, (8), pp. 1002-1007
34. Yu, Y.H., Kim, E., Park, D.E., et al.: 'Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA', Eur. J. Pharm. Biopharm., 2012, 80, (2), pp. 268-273
35. Wu, J., Huang, W., He, Z.: 'Dendrimers as carriers for siRNA delivery and gene silencing: a review', ScientificWorldJournal, 2013, 2013, p. 630654
36. Zhou, J., Wu, J., Hafdi, N., Behr, J.P., Erbacher, P., Peng, L.: 'Pamam dendrimers for efficient siRNA delivery and potent gene silencing', Chem. Commun. (Camb.), 2006, (22), pp. 2362-2364
37. Boussif, O., Lezoualc'h, F., Zanta, M.A., et al.: 'A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine', Proc. Natl. Acad. Sci. USA, 1995, 92, (16), pp. 7297-7301
38. Tiwari, G., Tiwari, R., Rai, A.K.: 'Cyclodextrins in delivery systems: applications', J. Pharm. Bioallied Sci., 2010, 2, (2), pp. 72-79
39. O'Mahony, A.M., Ogier, J., Darcy, R., Cryan, J.F., O'Driscoll, CM.: 'Cationic and pegylated amphiphilic cyclodextrins: co-formulation opportunities for neuronal siRNA delivery', PLoS One, 2013, 8, (6), p. E66413
40. Alabi, C, Vegas, A., Anderson, D.: 'Attacking the genome: emerging siRNA nanocarriers from concept to clinic', Curr. Opin. Pharmacol, 2012, 12, (4), pp. 427-433
41. Godinho, B.M., Ogier, J.R., Darcy, R., O'Driscoll, CM., Cryan, J.F.: 'Self-assembling modified beta-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease', Mol. Pharm., 2013, 10, (2), pp. 640-649
42. Tsutsumi, T., Arima, H., Hirayama, F., Uekama, K.: 'Potential use of dendrimer/A-cyclodextrin conjugate as a novel carrier for small interfering RNA (siRNA)', J. Incl. Phenom. Macro., 56, (1-2), pp. 81-84
43. Bonnet, M.E., Erbacher, P., Bolcato-Bellemin, A.L.: 'Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response', Pharm. Res., 2008, 25, (12), pp. 2972-2982
44. Gusachenko Simonova, O., Kravchuk, Y., Konevets, D., Silnikov, V., Vlassov, V. V., Zenkova, M.A.: 'Transfection efficiency of 25-kDa PEI-cholesterol conjugates with different levels of modification', J. Biomater. Sci. Polym. Ed., 2009, 20, (7-8), pp. 1091-1110
45. Essex, S., Navarro, G., Sabhachandani, P., et al.: 'Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors', Gene Ther., 2014
46. Tseng, S.J., Zeng, Y.-F., Deng, Y.-F., Yang, P.-C, Liu, J.-R., Kempson, I.M.: 'Switchable delivery of small interfering RNA using a negatively charged pH-responsive polyethylenimine-based polyelectrolyte complex', Chem. Commun., 2013, 49, (26), pp. 2670-2672
47. Ragelle, H., Vandermeulen, G., Préat, V.: 'Chitosan-based siRNA delivery systems', J. Control. Release, 2013, 172, (1), pp. 207-218
48. Howard, K.A., Rahbek, U.L., Liu, X., et al.: 'RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system', Mol. Ther., 2006, 14, (4), pp. 476-484
49. Katas, H., Alpar, H.O.: 'Development and characterisation of chitosan nanoparticles for siRNA delivery', J. Control. Release, 2006, 115, (2), pp. 216-225
50. Malhotra, M., Tomaro-Duchesneau, C, Saha, S., Prakash, S.: 'Intranasal, siRNA delivery to the brain by TAT/MGF tagged pegylated chitosan nanoparticles', J. Pharm., 2013, 2013, p. 10
51. Xia, T., Kovochich, M., Liong, M., et al.: 'Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs', ACS Nano, 2009, 3, (10), pp. 3273-3286
52. Shen, J., Kim, H.C, Su, H., et al.: 'Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics', Theranostics, 2014, 4, (5), pp. 487-497
53. Li, X, Chen, Y., Wang, M., Ma, Y, Xia, W., Gu, H.: 'A mesoporous silica nanoparticle-PEI-fusogenic peptide system for siRNA delivery in cancer therapy', Biomaterials, 2013, 34, (4), pp. 1391-1401
54. Rosi, N.L., Giljohann, D.A., Thaxton, C.S., Lytton-Jean, A.K., Han, M.S., Mirkin, C.A.: 'Oligonucleotide-modified gold nanoparticles for intracellular gene regulation', Science, 2006, 312, (5776), pp. 1027-1030
55. Oishi, M., Nakaogami, J., Ishii, T., Nagasaki, Y: 'Smart pegylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing', Chem. Lett, 2006, 35, (9), pp. 1046-1047
56. Lytton-Jean, A.K.R., Langer, R., Anderson, D.G.: 'Five years of siRNA delivery: spotlight on gold nanoparticles', Small, 2011, 7, (14), pp. 1932-1937
57. Siu, K.S., Zheng, X., Liu, Y, et al: 'Single-walled carbon nanotubes noncovalently functionalized with lipid modified polyethylenimine for siRNA delivery in vitro and in vivo', Bioconjug. Chem., 2014, 25, (10), pp. 1744-1751
58. Siu, K.S., Chen, D., Zheng, X., et al.: 'Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma', Biomaterials, 2014, 35, (10), pp. 3435-3442
59. Wu, X., Yamamoto, H., Nakanishi, H., et al.: 'Innovative delivery of siRNA to solid tumors by super carbonate apatite', PLoS One, 2015, 10, (3), p. E0116022
60. Chua, M., Tiash, S., Fatemian, T., Noordin, M., Keng, C, Chowdhury, E.: 'Carbonate apatite-facilitated intracellular delivery of C-Ros1 small interfering RNA sensitises Mcf-7 breast cancer cells to cisplatin and paclitaxel', OA Cancer, 2013, 1, (7)
61. Jiang, S., Eltoukhy, A.A., Love, K.T., Langer, R., Anderson, D.G.: 'Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery', Nano Lett., 2013, 13, (3), pp. 1059-1064
62. Kim, J., Kim, H.S., Lee, N., et al.: 'Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery', Angew. Chem. Int. Ed. Engl., 2008, 47, (44), pp. 8438-8441
63. Meyer, E.E., Lin, Q., Hassenkam, T., Oroudjev, E., Israelachvili, J.N.: 'Origin of the long-range attraction between surfactant-coated surfaces', Proc. Natl. Acad. Sci. USA, 2005, 102, (19), pp. 6839-6842
64. Duan, J., Dong, J., Zhang, T., etal.: 'Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis', Nanomedicine (Lond.), 2014, 9, (6), pp. 789-801
65. Oh, Y.K., Park, T.G.: 'satiRNA delivery systems for cancer treatment', Adv. Drug Deliv. Rev., 2009, 61, (10), pp. 850-862
66. Ellington, A.D., Szostak, J.W.: 'In vitro selection of RNA molecules that bind specific ligands', Nature, 1990, 346, (6287), pp. 818-822
67. Dassie, J.P., Liu, XY, Thomas, G.S., et al.: 'Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors', Nat. Biotechnol, 2009, 27, (9), pp. 839-849
68. McNamara, J.O. 2nd, Andrechek, E.R., Wang, Y, et al.: 'Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras', Nat. Biotechnol, 2006, 24, (8), pp. 1005-1015
69. Wang, J., Lu, Z., Wientjes, M.G., Au, J.L.: 'Delivery of siRNA therapeutics: barriers and carriers', AAPS J., 2010, 12, (4), pp. 492-503
70. Crombez, L., Charnet, A., Morris, M.C, Aldrian-Herrada, G., Heitz, F., Divita, G.: 'A non-covalent peptide-based strategy for siRNA delivery', Biochem. Soc. Trans., 2007, 35, (Pt 1), pp. 44-46
71. Crombez, L., Morris, M.C, Dufort, S., et al: 'Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth', Nucleic Acids Res., 2009, 37, (14), pp. 4559-4569
72. Andaloussi, S.E., Lehto, T., Mager, I., et al: 'Design of a peptide-based vector, Pepfect6, for efficient delivery of siRNA in cell culture and systemically in vivo', Nucleic Acids Res., 2011, 39, (9), pp. 3972-3987
73. Crombez, L., Divita, G.: 'A non-covalent peptide-based strategy for siRNA delivery', Methods Mol. Biol, 2011, 683, pp. 349-360
74. Khalil, I.A., Kogure, K., Akita, H., Harashima, H.: 'Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery', Pharmacol. Rev., 2006, 58, (1), pp. 32-45
75. Zuhorn, I.S., Kalicharan, R., Hoekstra, D.: 'Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis', J. Biol. Chem., 2002, 277, (20), pp. 18021-18028
76. Friend, D.S., Papahadjopoulos, D., Debs, R.J.: 'Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes', Biochim. Biophys. Acta, 1996, 1278, (1), pp. 41-50
77. Leonetti, C, Biroccio, A., Benassi, B., et al: 'Encapsulation of C-Myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line', Cancer Gene Ther., 2001, 8, (6), pp. 459-468
78. Takeshita, F., Minakuchi, Y, Nagahara, S., et al: 'Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo', Proc. Natl. Acad. Sci. USA, 2005, 102, (34), pp. 12177-12182
79. Reich, S.J., Fosnot, J., Kuroki, A., et al: 'Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model', Mol. Vis., 2003, 9, pp. 210-216
80. Shen, J., Samul, R., Silva, R.L., et al: 'Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1', Gene Ther., 2006, 13, (3), pp. 225-234
81. Dorn, G, Patel, S., Wotherspoon, G., et al: 'satiRNA relieves chronic neuropathic pain', Nucleic Acids Res., 2004, 32, (5), p. E49
82. Luo, M.C, Zhang, D.Q., Ma, S.W., et al: 'An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons', Mol. Pain, 2005, 1, p. 29
83. Aharinejad, S., Paulus, P., Sioud, M., et al: 'Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice', Cancer Res., 2004, 64, (15), pp. 5378-5384
84. Leng, Q., Mixson, A.J.: 'Small interfering RNA targeting RAFf-1 inhibits tumor growth in vitro and in vivo', Cancer Gene Ther., 2005, 12, (8), pp. 682-690
85. Sarret, P., Dore-Savard, L., Beaudet, N.: 'Direct application of siRNA for in vivo pain research', Methods Mol. Biol, 2010, 623, pp. 383-395
86. Barik, S.: 'Intranasal delivery of antiviral siRNA', Methods Mol. Biol, 2011, 721, pp. 333-338
87. Whitehead, K.A, Langer, R., Anderson, D.G.: 'Knocking down barriers: advances in siRNA delivery', Nat. Rev. Drug Discov., 2009, 8, (2), pp. 129-138
88. Takahashi, Y, Nishikawa, M., Takakura, Y: 'Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy', Adv. Drug Deliv. Rev., 2009, 61, (9), pp. 760-766
89. Greish, K.: 'Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines', J. Drug Target, 2007, 15, (7-8), pp. 457-464
90. Jain, R.K.: 'Transport of molecules in the tumor interstitium: a review', Cancer Res., 1987, 47, (12), pp. 3039-3051
91. Mukherjee, S., Ghosh, R.N., Maxfield, F.R.: 'Endocytosis', Physiol. Rev., 1997, 77, (3), pp. 759-803
92. Nguyen, J., Szoka, F.C.: 'Nucleic acid delivery: the missing pieces of the puzzle?', Acc. Chem. Res., 2012, 45, (7), pp. 1153-1162
93. Goula, D., Becker, N., Lemkine, G.F., et al: 'Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes', Gene Ther., 2000, 7, (6), pp. 499-504
94. Varkouhi, A.K., Scholte, M., Storm, G., Haisma, H.J.: 'Endosomal escape pathways for delivery of biologicals', J. Control. Release, 2011, 151, (3), pp. 220-228
95. Cho, Y.W., Kim, J.D., Park, K.: 'Polycation gene delivery systems: escape from endosomes to cytosol', J. Pharm. Pharmacol, 2003, 55, (6), pp. 721-734
96. Shiraishi, T., Pankratova, S., Nielsen, P.E.: 'Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides', Chem. Biol, 2005, 12, (8), pp. 923-929
97. Perez-Martinez, F.C., Guerra, J., Posadas, I., Cena, V.: 'Barriers to non-viral vector-mediated gene delivery in the nervous system', Pharm. Res., 2011, 28, (8), pp. 1843-1858
98. Klibanov, A.L., Maruyama, K., Beckerleg, A.M., Torchilin, V.P., Huang, L.: 'Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target', Biochim. Biophys. Acta, 1991, 1062, (2), pp. 142-148
99. Norman, M.E., Williams, P., Illum, L.: 'Influence of block copolymers on the adsorption of plasma proteins to microspheres', Biomaterials, 1993, 14, (3), pp. 193-202
100. Zuckerman, J.E., Gritli, I., Tolcher, A., et al: 'Correlating animal and human phase Ia/Ib clinical data with Calaa-01, a targeted, polymer-based nanoparticle containing siRNA', Proc. Natl. Acad. Sci., 2014, 111, (31), pp. 11449-11454